AIMC Topic: Drug Discovery

Clear Filters Showing 611 to 620 of 1689 articles

Biomolecular NMR spectroscopy in the era of artificial intelligence.

Structure (London, England : 1993)
Biomolecular nuclear magnetic resonance (NMR) spectroscopy and artificial intelligence (AI) have a burgeoning synergy. Deep learning-based structural predictors have forever changed structural biology, yet these tools currently face limitations in ac...

DeepADRA2A: predicting adrenergic α2a inhibitors using deep learning.

Journal of biomolecular structure & dynamics
Adrenergic α2a (ADRA2A) receptors play a crucial role in modulating various physiological actions, thereby influencing the proper functioning of different systems in the body. ADRA2A regulation is associated with a wide range of effects, including al...

Epigenetic target identification strategy based on multi-feature learning.

Journal of biomolecular structure & dynamics
The identification of potential epigenetic targets for a known bioactive compound is essential and promising as more and more epigenetic drugs are used in cancer clinical treatment and the availability of chemogenomic data related to epigenetics incr...

Recent Studies of Artificial Intelligence on Drug Absorption.

Journal of chemical information and modeling
Absorption is an important area of research in pharmacochemistry and drug development, because the drug has to be absorbed before any drug effects can occur. Furthermore, the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profi...

Learning on topological surface and geometric structure for 3D molecular generation.

Nature computational science
Highly effective de novo design is a grand challenge of computer-aided drug discovery. Practical structure-specific three-dimensional molecule generations have started to emerge in recent years, but most approaches treat the target structure as a con...

Multi-Label Classification With Dual Tail-Node Augmentation for Drug Repositioning.

IEEE/ACM transactions on computational biology and bioinformatics
Due to the lengthy and costly process of new drug discovery, increasing attention has been paid to drug repositioning, i.e., identifying new drug-disease associations. Current machine learning methods for drug repositioning mainly leverage matrix fac...

RefinePocket: An Attention-Enhanced and Mask-Guided Deep Learning Approach for Protein Binding Site Prediction.

IEEE/ACM transactions on computational biology and bioinformatics
Protein binding site prediction is an important prerequisite task of drug discovery and design. While binding sites are very small, irregular and varied in shape, making the prediction very challenging. Standard 3D U-Net has been adopted to predict b...

Molecular Joint Representation Learning via Multi-Modal Information of SMILES and Graphs.

IEEE/ACM transactions on computational biology and bioinformatics
In recent years, artificial intelligence has played an important role on accelerating the whole process of drug discovery. Various of molecular representation schemes of different modals (e.g., textual sequence or graph) are developed. By digitally e...

Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best Practices.

Clinical pharmacology and therapeutics
Recent breakthroughs in artificial intelligence (AI) and machine learning (ML) have ushered in a new era of possibilities across various scientific domains. One area where these advancements hold significant promise is model-informed drug discovery a...

A pharmacophore-guided deep learning approach for bioactive molecular generation.

Nature communications
The rational design of novel molecules with the desired bioactivity is a critical but challenging task in drug discovery, especially when treating a novel target family or understudied targets. We propose a Pharmacophore-Guided deep learning approach...